Stability differences between condition 1 and other conditions across participants on the non-hemiparetic side (NHP) side. by Hyung Suk Yang (20442438)

Subjects:

Stability differences between condition 1 and other conditions across participants on the hemiparetic (HP) side. by Hyung Suk Yang (20442438)

Subjects:

Average stability values (mean ± standard deviation) and statistical results. by Hyung Suk Yang (20442438)

Subjects:

Individual stability values for different gait events under various conditions. by Hyung Suk Yang (20442438)

Subjects:

Dynamic stability based on the Feasible Stability Region (FSR). by Hyung Suk Yang (20442438)

Subjects:

Spatial dry and wet side fitting of the TS-NDVI characteristics for different time periods in the Santun River Irrigation Area: (a) 2006/05; (b) 2007/04; (c) 2008/10; (d) 2009/08;... by Yuxin Wei (11510974)

S2 File - by Phuong Nguyen Thi Thu (11503489)

Subjects:

Clinical and demographic characteristics of the patients (n = 280). by Phuong Nguyen Thi Thu (11503489)

Subjects:

Data at baseline and after 12 weeks of treatment with DAA therapy (n = 280). by Phuong Nguyen Thi Thu (11503489)

Subjects:

Metabolic, renal, and hematological changes after 12 weeks of direct-acting antiviral treatment (n = 280). by Phuong Nguyen Thi Thu (11503489)

Subjects:

Relationship between changes in clinical laboratory r and hepatitis C viral genotypes (n = 280). by Phuong Nguyen Thi Thu (11503489)

Subjects:

Comparison of anemia incidence before and after 12 weeks of treatment with DAAs in the study population and among HCV genotypes (n = 280). by Phuong Nguyen Thi Thu (11503489)

Subjects:

Flowchart of the study. by Phuong Nguyen Thi Thu (11503489)

Subjects:

Multiple logistic regression analysis showing the factors associated with anemia in patients with HCV infection after 12 weeks of DAA therapy (n = 280). by Phuong Nguyen Thi Thu (11503489)

Subjects:

Theoretical framework. by Dinku Mechal (21273002)

“…Holding other variables constant, a one-unit increase in demand and supply side risks results in 19.1% and 13.1% lead to decrease in operational performance of manufacturing companies, respectively. …”

Supplementary file survey questioner annex. by Dinku Mechal (21273002)

“…Holding other variables constant, a one-unit increase in demand and supply side risks results in 19.1% and 13.1% lead to decrease in operational performance of manufacturing companies, respectively. …”

An overview of study characteristics. by Akhmedkhan Dubayev (17879559)

“…</p><p>Results</p><p>Twenty-five studies were included (5 randomized controlled trials, 20 non-randomized controlled trials). Overall, risk of bias was low. Compared with the contralateral side or controls, there were significant alterations in somatosensory function of the surgical site in PPSP-patients. …”

Summary of NOS bias assessments. by Akhmedkhan Dubayev (17879559)

“…</p><p>Results</p><p>Twenty-five studies were included (5 randomized controlled trials, 20 non-randomized controlled trials). Overall, risk of bias was low. Compared with the contralateral side or controls, there were significant alterations in somatosensory function of the surgical site in PPSP-patients. …”

QST characteristics. by Akhmedkhan Dubayev (17879559)

“…</p><p>Results</p><p>Twenty-five studies were included (5 randomized controlled trials, 20 non-randomized controlled trials). Overall, risk of bias was low. Compared with the contralateral side or controls, there were significant alterations in somatosensory function of the surgical site in PPSP-patients. …”

Table2_Clinical benefit and risk of elemene in cancer patients undergoing chemotherapy: a systematic review and meta-analysis.docx by Yanhong Pan (3271245)

“…However, the administration of elemene has been found to significantly increase the incidence of phlebitis in patients undergoing chemotherapy (RR:3.41, 95% CI:1.47–7.93, p = 0.004). …”